Author: STITCHES Newsletter

Higher Morbidity in Robotic Pancreatoduodenectomy Conversion

Robotic pancreatoduodenectomy has greater postoperative complication risks than laparoscopic, especially after conversion. Major morbidity rates are 49% in robotic (rpd) versus 31% in laparoscopic (lpd) after conversion (p=0.021). Conversion required in 12% of cases, with no significant difference between robotic (12%) and laparoscopic (14%). Surgeons should assess conversion risks when choosing robotic methods, emphasizing structured […]

Analgesia Revolution: Rectus Sheath vs. Epidural for Open Surgery

Rectus sheath catheters offer a safe pain management alternative to thoracic epidural analgesia, reducing complications and costs for open surgery patients. No significant difference in postoperative pain scores or opioid use between the two methods. Rectus sheath catheters cut the risk of hypotension by 60% and lower costs between $500 and $6632 per case. These […]

Missing Data Biases Outcomes in Cancer Treatment Studies

Non-cancer center patients have worse survival outcomes and more missing data. Missing data prevalence was significantly higher at non-cancer centers (e.g., NSCLC: 42% vs 13% at cancer centers). Three-year overall survival was lower for patients with missing data across all cancers (e.g., breast: 63% vs 81%). Consider the implications of missing data in decision-making and […]

Standardized Endoscopy Could Improve Gastric Cancer Outcomes

Diagnostic endoscopy for gastric cancer is underused, leading to late-stage diagnoses and worse survival rates. 73% of stage I gastric cancer patients are symptomatic, yet many are diagnosed late. Median overall survival varies drastically: 47 months for stage II versus 11 months for stage IV. Surgeons should advocate for standardized endoscopy protocols to improve early […]

Endoscopic dissection proves effective for early esophageal cancer

Endoscopic submucosal dissection (ESD) can be a viable option for patients with esophageal squamous high-grade dysplasia and early squamous cell carcinoma, challenging the conventional referral for surgical intervention. Curative resection rates were significantly higher for absolute criteria lesions at 71.8%, compared to just 19.4% for outside criteria lesions. Of the outside criteria group, nearly 20% […]

High CA19-9 Levels Signal Aggressive Pancreatic Cancer

Patients with biological borderline resectable pancreatic cancer and CA19-9 levels ≥500 u/ml show worse outcomes and need tailored surgical approaches. Cancer-specific survival is significantly lower in patients with CA19-9 ≥500 u/ml compared to those with levels <37 u/ml (p = 0.03). Higher CA19-9 is linked to increased genomic mutations, with tumors showing ≥3 driver gene […]

Endoscopic and Surgical Advances in Achalasia Treatment

Minimally invasive strategies are transforming achalasia management. Laparoscopic myotomy, POEM, and emerging techniques like peroral oesophageal plication show promising outcomes. Individualized treatment based on high-resolution manometry, patient co-morbidities, and procedural risks is now essential. Comprehensive treatment offers significant symptom relief and quality-of-life improvement. Addressing post-treatment reflux and surveillance for malignancy remains critical for long-term patient […]

Surgical trainees struggle with Commission on Cancer standards.

Only 30% of trainees have formal training on COC operative standards. Correct answer rates: 30% for standards, 50% for cancer surgery principles. Incorporating education on these standards in training is crucial for improving surgical quality. Fellows have much higher familiarity (68%) compared to residents (24%). A significant 71% of residents participate in operative documentation, indicating […]

Linking Postpancreatectomy Acute Pancreatitis to Mortality Risk

Postpancreatectomy acute pancreatitis (PPAP) is a key factor increasing mortality after pancreatoduodenectomy. 24.3% of patients developed clinically relevant postoperative pancreatic fistula (CR-POP), with 90-day mortality at 9% in this group. PPAP is the strongest predictor of CR-POP (odds ratio 11.76) and 90-day mortality (odds ratio 4.88). Understanding these links can help refine patient selection and […]

Examining Impact of Violence Intervention Programs on Patient Outcomes

Violence intervention programs are critical for reducing negative outcomes in firearm violence patients, but their availability varies significantly. 64.3% of patients were treated at facilities with VIP services, but many high-risk patients in non-VIP facilities lack access. Within VIP facilities, 81.5% of patients did not receive VIP services; younger, Medicaid users, and those with assault-related […]